Skip to main content
Clinical Trials/NCT00978887
NCT00978887CompletedPhase 3

Efficacy of Retorna Facial Cream Usage in the Treatment of Facial Wrinkles

Catalysis SL2 sites in 1 country148 target enrollmentStarted: October 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
148
Locations
2
Primary Endpoint
Total correction or improvement of facial wrinkles at the end of treatment (4 weeks)

Study Overview

Brief Summary

The purpose of the study is to assess the efficacy of Retorna facial cream usage in the reduction or total correction of facial wrinkles. The duration of this double-blind placebo controlled phase 3 clinical trial will be 4 weeks. The estimated number of women to be recruited and randomized for the study is 148. Occurrence of adverse effects will also be evaluated.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
20 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Facial wrinkles
  • Signed informed consent
  • Given verbal agreement on solar exposure prevention within hours of intense solar radiation (10 am - 4 pm) by the usage of physical protection methods such as umbrellas, caps and hats.

Exclusion Criteria

  • Pregnancy
  • Breast-feeding
  • Use of steroids within 6 months.
  • Patients under other experimental treatment
  • Decompensated concomitant diseases
  • Malignant neoplastic conditions.
  • Alcoholism
  • Handicap and/or psychiatric condition preventing treatment accomplishment.

Outcomes

Primary Outcomes

Total correction or improvement of facial wrinkles at the end of treatment (4 weeks)

Time Frame: 4 weeks

Secondary Outcomes

  • Presence of adverse effects within the 4 week treatment period(4 weeks)

Investigators

Sponsor Class
Industry

Study Sites (2)

Loading locations...

Similar Trials